搜索临床试验以:APR-246 (eprenetapopt) Venetoclax Rituximab in CLL
总计276个结果
-
Aprea Therapeutics终止套细胞淋巴瘤 | 慢性淋巴细胞白血病 | 非霍奇金淋巴瘤美国
-
Aprea Therapeutics完全的
-
AbbVieGenentech, Inc.完全的慢性淋巴细胞白血病 (CLL) | 小淋巴细胞淋巴瘤 (SLL) | 急性髓系白血病 (AML) | 多发性骨髓瘤 (MM) | 非霍奇金淋巴瘤 (NHL)日本
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AbbVie招聘中
-
AbbVieGenentech, Inc.完全的
-
ZePing ZhouGuizhou Provincial People's Hospital; Second Xiangya Hospital of Central South University; Tianjin... 和其他合作者招聘中
-
Curis, Inc.The Leukemia and Lymphoma Society完全的淋巴瘤 | 难治性淋巴瘤 | 复发性淋巴瘤 | 复发和/或难治性淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 (DLBCL) | 难治性弥漫性大 B 细胞淋巴瘤 (DLBCL) | 复发和/或难治性弥漫性大 B 细胞淋巴瘤 (DLBCL) | 双打击淋巴瘤 (DHL) | 三重打击淋巴瘤 (THL) | 双表达淋巴瘤 (DEL) | 高级别 B 细胞淋巴瘤 (HGBL)美国
-
University of UlmPfizer; AbbVie; Ludwig-Maximilians - University of Munich; Zentrum für Klinische Studien Ulm; University...尚未招聘
-
University of California, San Diego主动,不招人
-
Memorial Sloan Kettering Cancer Center完全的
-
Dalian Medical University尚未招聘
-
Aprea Therapeutics完全的
-
First Affiliated Hospital of Zhejiang UniversityXiangya Hospital of Central South University; Second Affiliated Hospital, School of Medicine... 和其他合作者招聘中
-
AbbVieRoche-Genentech完全的
-
Georgetown UniversityHackensack Meridian Health主动,不招人
-
Gruppo Italiano Malattie EMatologiche dell'Adulto主动,不招人
-
The First Affiliated Hospital of Soochow UniversityThe Second People's Hospital of Huai'an; First Affiliated Hospital Bengbu Medical College; Jining... 和其他合作者招聘中
-
Paolo Ghia招聘中
-
Hoffmann-La Roche完全的弥漫性大 B 细胞淋巴瘤 | 高级别 B 细胞淋巴瘤美国, 西班牙, 澳大利亚, 丹麦
-
ZePing ZhouGuizhou Provincial People's Hospital; Second Xiangya Hospital of Central South University; Tianjin... 和其他合作者招聘中
-
Hoffmann-La Roche终止淋巴瘤,大 B 细胞,弥漫性 | 滤泡性淋巴瘤美国, 澳大利亚, 德国, 大韩民国, 新西兰
-
University of CagliariAzienda Ospedaliero Universitaria di Cagliari招聘中
-
The Second Affiliated Hospital of Kunming Medical...尚未招聘急性髓性白血病 | 地西他滨 | 维奈托克 | 老年急性髓性白血病患者 | 不合格、新诊断 AML中国
-
The First Affiliated Hospital with Nanjing Medical...Huai'an First People's Hospital; Yancheng First People's Hospital; The Affiliated Jiangning Hospital...招聘中
-
Ming HouPeking Union Medical College Hospital; Cancer Institute and Hospital, Chinese Academy of Medical... 和其他合作者完全的
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)主动,不招人复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性套细胞淋巴瘤 | 复发性边缘区淋巴瘤 | 难治性 B 细胞非霍奇金淋巴瘤 | 复发性小淋巴细胞淋巴瘤 | 复发性 B 细胞非霍奇金淋巴瘤 | 复发性 3a 级滤泡性淋巴瘤 | 难治性 1 级滤泡性淋巴瘤 | 难治性 2 级滤泡性淋巴瘤 | 难治性 3a 级滤泡性淋巴瘤 | 难治性套细胞淋巴瘤 | 难治性小淋巴细胞淋巴瘤 | 难治性边缘区淋巴瘤美国
-
MEI Pharma, Inc.Kyowa Kirin, Inc.撤销
-
H. Lee Moffitt Cancer Center and Research InstituteAprea Therapeutics完全的
-
Groupe Francophone des MyelodysplasiesAprea Therapeutics未知
-
Nordic Lymphoma GroupAstraZeneca主动,不招人
-
Hoffmann-La Roche完全的